Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model.

TitleImmunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model.
Publication TypeJournal Article
Year of Publication2015
AuthorsSlavuljica I, Kveštak D, Huszthy PCsaba, Kosmac K, Britt WJ, Jonjić S
JournalCell Mol Immunol
Volume12
Issue2
Pagination180-91
Date Published2015 Mar
ISSN2042-0226
KeywordsAnimals, Animals, Newborn, Central Nervous System Diseases, Cytomegalovirus, Cytomegalovirus Infections, Disease Models, Animal, Humans, Mice
Abstract

Congenital human cytomegalovirus infection is a leading infectious cause of long-term neurodevelopmental sequelae, including mental retardation and hearing defects. Strict species specificity of cytomegaloviruses has restricted the scope of studies of cytomegalovirus infection in animal models. To investigate the pathogenesis of congenital human cytomegalovirus infection, we developed a mouse cytomegalovirus model that recapitulates the major characteristics of central nervous system infection in human infants, including the route of neuroinvasion and neuropathological findings. Following intraperitoneal inoculation of newborn animals with mouse cytomegalovirus, the virus disseminates to the central nervous system during high-level viremia and replicates in the brain parenchyma, resulting in a focal but widespread, non-necrotizing encephalitis. Central nervous system infection is coupled with the recruitment of resident and peripheral immune cells as well as the expression of a large number of pro-inflammatory cytokines. Although infiltration of cellular constituents of the innate immune response characterizes the early immune response in the central nervous system, resolution of productive infection requires virus-specific CD8(+) T cells. Perinatal mouse cytomegalovirus infection results in profoundly altered postnatal development of the mouse central nervous system and long-term motor and sensory disabilities. Based on an enhanced understanding of the pathogenesis of this infection, prospects for novel intervention strategies aimed to improve the outcome of congenital human cytomegalovirus infection are proposed.

DOI10.1038/cmi.2014.51
Alternate JournalCell. Mol. Immunol.
PubMed ID25042632
PubMed Central IDPMC4654296
Grant ListR01 NS065845 / NS / NINDS NIH HHS / United States
R01 AI089956 / AI / NIAID NIH HHS / United States
T32 AI007051 / AI / NIAID NIH HHS / United States
1R01AI083201-01 / AI / NIAID NIH HHS / United States
R01 AI083201 / AI / NIAID NIH HHS / United States
1R01AI089956-01A1 / AI / NIAID NIH HHS / United States
1R01NS065845-01 / NS / NINDS NIH HHS / United States